Archive for May, 2009

Biotechnology Management Papers

These papers are from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: Financial opportunities for early stage biotech companies Tamara Jones The […]


The changing roles of CRO

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. The changing roles of CRO Alex Bao […]


Discovering potential drug targets

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Discovering potential drug targets Myung K. Kim […]


Financial opportunities for early stage biotech companies

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Financial opportunities for early stage biotech companies […]


Discussing the worldVIEW Project

In this video Jeremy Abbate, director of global media at Scientific American, and I discuss the worldVIEW project, where we profiled the biotechnology innovation climate around the world on a country-by-country basis. More details on the project are in my previous post, and the video is below. Scientific American’s Biotechnology Scorecard Uploaded by dwjtelevision – […]


Biotech protesters and the economic crisis

Where are the biotechnology protesters? I’ve enjoyed the conversations I’ve had with biotechnology protest organizers in the past. They are noticably absent from this year’s Biotechnology Industry Organization conference in Atlanta. One must ask the question: Have they lost their interest in representing their views at the conference, or is there a connection to the […]


Scientific American WorldVIEW: Measuring Global Biotechnology Innovation

After months of preparation, the Scientific American worldVIEW project has launched. I had the pleasure of serving as lead editorial consultant of this project, and my mission was to cut through the marketing messages and develop a coherent measure of biotechnology innovation on a country-by-country basis. You can hear me talk about the project and […]


VC's don't read business plans; So, what to do?

A recent UMD study has found that VCs pay little attention ot the content of business plans.This is not much of a surprise. I’m generally bearish on business plans, but I do recognize their important role. Having written several business plans and having successfully competed in business plan competitions, I’ve recognized that many of the […]


Creative Destruction in Biotechnology

For all the talk of the numerous biotechnology companies with mere months of cash left and the predictions of looming liquidations, mergers, and acquisitions, it is important to note that a measure of destruction can benefit industry progress. Economy Joseph Schumpeter coined a term for industrial progress through destruction: creative destruction. In this process, growth […]